A Bit more Stats and info on this. As we know it was way...

A Bit more Stats and info on this. As we know it was way oversubscribed with huge Scalebacks.

NVC will have 35 clinics and GXL has 126 clinics. GXL has shops and retail which has been a drag on its earnings where as NVC has none of that Drag, so its a huge Plus for NVC. But GXL has all its 126 clinics integrated over 9 years but NVC has 34 to be integrated after listing so that's a hugish plus for GXl: Mind you the team who did that Integration at GXL are the team behind NVC so that's a plus for NVC. GXL is valued at $648 Mil at last night's closed price. Based on pure numbers then NVC should be valued at 35/126 multiplied by $648 mil = $180 Mil but as there is an execution risk for NVC with its yet to be integrated 34 practices even though the people behind it were the experts at GXL, we could remove $50 Mil from its valuation so NVC is roughly $130 Mil. As GXL is listed and NVC is starting now so GXL deserves a premium. so remove another $30 mil which values NVC at $100 Mil. But NVC won't have the drag of GXL's retail products etc so we can add say just a very conservative $5 Mil for NVC which is now $105 Mil. Take another 25% value off for what ever other reasons now NVC should be roughly $80 Mil. But NVC is valued after listing at 50 Mil. I believe that NVC will catch up with GXL in 12 months with its integration and by 12 months after listing it will have 50 clinics minimum and should be valued at around $300 Mil by Aug 2016 at a reasonable conservative rate, provided the NVC guys do what they did at GXL with their integration. In summary the upside is very high for this IPO, no wonder Fundies and Instos went like bees to the honey pot. Cheers.